Review of major intervention studies in hypertension and hyperlipidemia: Focus on coronary heart disease

American Heart Journal

Volumn 116, Issue 6 PART 2, 1988, Pages 1708-1712

  Middeke, Martin ^a   Holzgreve, Heinrich ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COLESTYRAMINE; DIURETIC AGENT; GEMFIBROZIL; GUANETHIDINE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; METHYLDOPA; METOPROLOL; PRAZOSIN; PROPRANOLOL; RESERPINE; SPIRONOLACTONE; VASODILATOR AGENT;

ADULT; AGED; CLINICAL TRIAL; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; SHORT SURVEY;

ADULT; CORONARY DISEASE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; MIDDLE AGE;

EID: 0024202987     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(88)90219-0     Document Type: Review

References (27)

1. Framingham study. Systolic versus diastolic blood pressure and risk of coronary heart disease
2. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg
3. Treatment of mild hypertension Results of a ten-year intervention trial
4. Report by the Management Committee The Australian Therapeutic Trial in Mild Hypertension
5. Treatment of mild hypertension: a five-year controlled drug trial. The Oslo study
6. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial
7. Five year findings of the Hypertension Detection and Follow-up Program I Reduction in mortality of persons with high blood pressure including mild hypertension
8. Five year findings of the Hypertension Detection and Follow-up Program II Mortality by race sex and age
9. Coronary heart disease after treatment of hypertension
10. Rationale for established antihypertensive treatment
11. MRC trial of treatment of mild hypertension principal results
12. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial
13. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol the International Prospective Primary Prevention Study in Hypertension
14. Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study
15. Serum lipoproteins during antihypertensive therapy with beta-blockers and diuretics: a controlled long-term comparative trial
16. Failure to reduce cholesterol as explanation for the limited efficacy of antihypertensive treatment in the reduction of coronary heart disease
17. Why does antihypertensive treatment prevent stroke but not myocardial infarction?
18. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men
19. The pathology of atherosclerosis—an update
20. The Lipid Research Clinics coronary primary prevention trial results I Reduction in incidence of coronary heart disease
21. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease
22. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts
23. Lipid and glucose metabolism under long-term antihypertensive therapy with enalapril and nifedipine
24. Effect of propranolol and prazosin on blood lipids. The Oslo study
25. 1-adrenergic inhibitor for systemic hypertension
26. Serum lipid changes in a one-year multicenter double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension
27. Background and design of the new US trial on diet and drug treatment of “mild” hypertension (TOMHS)